1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
DRTECH Corp.

DRTECH Corp.

KKRX:214680
3,470.00
KRW
+95.00
(+2.81%)
-179.98EPS
428.24BMarket Cap
Nov 12Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8,491.46
1,093.86
940.82
1,040.91
1,013.02
1,077.79
1,287.88
1,543.28
1,397.83
1,325.1
1,553.8
1,957.81
Basic EPS, GAAP
740.95
-13
-44
29
20
-141
74
103
-34
-262
-321
-194.36
Free Cash Flow per Basic Share
-6.16
-288.18
-149.9
-12.21
6.03
-158.52
-101.9
-47.58
-270.58
-348.86
-359.36
-222.61
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
- -
- -
Book Value per Share
2,597.83
677.92
641.33
708.62
762.81
639.17
779.06
1,031.98
1,159.24
976.47
913.3
1,009.73
Tangible Book Value per Share
2,467.62
649.21
606.87
668.91
729.71
557.39
714.06
971.31
1,109.99
943.38
890.18
987.58
Basic Weighted Avg Shares
4
33
41
43
47
51
55
58
66
74
75
64
Sales/Revenue/Turnover
30,197
36,639
38,804
44,714
47,845
55,268
70,277
89,481
92,439
97,559
116,304
126,233
Operating Margin (%)
4.94
6.68
-2.73
3.52
2.92
-9.93
3.35
5.49
-0.16
-12.41
-11.95
-7.94
Depreciation Expense
1,168
1,379
1,638
1,665
3,188
4,500
5,576
6,504
7,979
9,971
11,059
11,265
Net Income, GAAP
2,635
-435
-1,815
1,246
945
-7,230
4,038
5,972
-2,248
-19,290
-24,027
-12,532
Effective Tax Rate (%)
- -
- -
- -
9.7
17.13
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
8.73
-1.19
-4.68
2.79
1.97
-13.08
5.75
6.67
-2.43
-19.77
-20.66
-9.93
Working Capital
8,146
19,006
26,009
19,739
34,265
27,459
17,623
26,906
65,458
67,041
69,994
84,825
LT Debt
1,857
- -
9,784
- -
16,101
24,967
4,160
4,214
35,632
51,728
40,843
42,278
Total Equity
11,516
27,299
26,503
31,327
37,359
32,777
44,440
59,838
84,594
72,801
76,765
84,816
Return on Invested Capital (%)
- -
- -
- -
3.71
2.33
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
3.58
2.45
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-2.24
-6.75
4.31
2.75
-20.52
10.46
11.49
-3.12
-24.68
-32.36
-16.47

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
47,579
55,833
58,782
LT Borrowings
23,330
15,967
26,075
LT Finance Leases
17,513
16,973
16,204
Preferred Equity and Hybrid Capital
500
500
500
Shares Outstanding
83
83
83
Market Capitalization
878,595
684,093
428,237

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
137,809
142,399
174,722
Cash, Cash Equivalents & STI
27,299
28,579
48,497
Accounts Receivable, Net
52,665
60,384
68,889
Inventories
46,453
48,237
49,607
Total Current Liabilities
67,815
83,615
89,897
Payables & Accruals
- -
- -
- -
ST Debt
47,579
55,833
58,782
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.24%
20.62%
5.44%
Free Cash Flow
4,121.4%
102.98%
4.73%
Net Income, GAAP
-32.12%
107.37%
24.56%
Sales/Revenue/Turnover
14.75%
16.51%
19.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17,277
26,340
26,602
27,340
97,559
2025
25,371
33,551
34,036
23,346
116,304
2026
31,847
37,004
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-55
-77
-138
-345.25
-262
2025
-61
-80
38
-971.47
-321
2026
-10.6
25
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sung-Hyun Ahn
Full Time Employees
381
Sector
Health technology
Industry
Medical specialties
Address
SPG Dream building Seongnam-si GY South Korea 13558
IPO Date
Apr 20, 2015
Website
drtech.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
DRTECH Corporation (214680.KQ), founded in 2000 and headquartered in Seongnam-si, South Korea, develops, manufactures and sells flat-panel X-ray detectors and related imaging solutions for digital radiography, serving medical, dental, veterinary and industrial applications in South Korea and internationally. The company's core products include indirect and direct flat-panel detectors such as Exprimer, FLAATZ and RoseM for general radiography, mammography, dynamic imaging, dental, veterinary and industrial uses; premium digital mammography systems; low-dose mobile C-arm solutions like EXTRON; high-resolution long-length imaging systems with bucky stands; and the world's first bendable and curved detectors; complemented by imaging software including acquisition software, specialized UI software, DEPAI AI imaging processing, dual-energy X-ray imaging, advanced image reconstruction technology and AI CAD tools, as well as radiography, mammography and C-arm systems. In September 2025, DRTECH completed a private placement funding round raising approximately KRW 5 billion through the issuance of 2.375 million shares, bolstering its capacity for research, development and expansion in high-performance IGZO thin-film transistor detector technology amid ongoing global demand for advanced digital imaging components.